INTRODUCTION Vitiligo, characterized by patches of depigmented skin, is a common acquired disease affecting up to 2% of the population worldwide.1 The white macules and patches are cosmetically disfiguring and…

INTRODUCTION Cherry hemangiomas are common acquired lobular capillary proliferations that increase in prevalence with age.1 Although they are usually asymptomatic, some cases raise a cosmetic concern and may require treatment.…

INTRODUCTION Atopic Dermatitis (AD), or eczema, is a chronic inflammatory skin disease that is a significant cause of morbidity, quality-of-life impairment, and health-care costs. It is seen more commonly in…

INTRODUCTION Developing effective and well-tolerated topical dermatologic formulations is a long, often complex process that has provided a number of important products over the years.1 They remain the most common…

INTRODUCTION Acne vulgaris is a common skin condition that can affect the face as well as the trunk among adolescents and young adults.1 It can affect the quality of life…

INTRODUCTION The incidence of Candida infections has increased substantially in recent years in HIV, cancer, and immunosuppressive patients. Patients undergoing radio chemotherapy in oncology malignancies, HIV, onchomycosis, diabetic feet, and…

INTRODUCTION One of the newest technological advancements in the facial cosmeceutical category is the synthesis of recombinant growth factors and their incorporation into moisturizer formulations. The recombinant manufacturing technique removes…

INTRODUCTION Tinea corporis is a dermatophyte infection of the glabrous skin of the trunk and/or extremities. The disease is found worldwide and affects persons of all age groups, but the…

INTRODUCTION Skin aging as a result of chronologic (intrinsic) aging and photodamage (extrinsic) is a complex process that causes a significant change in the appearance and texture of the skin.1…

INTRODUCTION When the FDA approved Sculptra® (poly-L-lactic acid injectable (PLLA) in 2004 for HIV lipoatrophy, there were many questions about this product, given its safety profile of dermal papules and…

CASE REPORT A 41-year-old Caucasian female of Fitzpatrick skin phototype II with a history of acne and long-standing erythematotelangiectatic rosacea involving the nose, cheeks, forehead, and chin presented with a…

INTRODUCTION Vemurafenib is a potent and selective inhibitor of oncogenic BRAF kinase, which has been shown in clinical trials to improve the chances of survival of patients with late-stage melanoma,…